Willow Capital Expenditures vs Other Non Cash Items Analysis
WLLW Stock | CAD 0.07 0.01 6.25% |
Willow Biosciences financial indicator trend analysis is more than just analyzing Willow Biosciences current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Willow Biosciences is a good investment. Please check the relationship between Willow Biosciences Capital Expenditures and its Other Non Cash Items accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Willow Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Capital Expenditures vs Other Non Cash Items
Capital Expenditures vs Other Non Cash Items Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Willow Biosciences Capital Expenditures account and Other Non Cash Items. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Willow Biosciences' Capital Expenditures and Other Non Cash Items is 0.94. Overlapping area represents the amount of variation of Capital Expenditures that can explain the historical movement of Other Non Cash Items in the same time period over historical financial statements of Willow Biosciences, assuming nothing else is changed. The correlation between historical values of Willow Biosciences' Capital Expenditures and Other Non Cash Items is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Expenditures of Willow Biosciences are associated (or correlated) with its Other Non Cash Items. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Non Cash Items has no effect on the direction of Capital Expenditures i.e., Willow Biosciences' Capital Expenditures and Other Non Cash Items go up and down completely randomly.
Correlation Coefficient | 0.94 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Capital Expenditures
Capital Expenditures are funds used by Willow Biosciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Willow Biosciences operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Other Non Cash Items
Most indicators from Willow Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Willow Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Willow Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Willow Biosciences' Selling General Administrative is very stable compared to the past year. As of the 13th of December 2024, Enterprise Value is likely to grow to about 14.8 M, while Tax Provision is likely to drop (5.2 K).
Willow Biosciences fundamental ratios Correlations
Click cells to compare fundamentals
Willow Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Willow Biosciences fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Current Liabilities | 1.8M | 1.6M | 1.4M | 1.7M | 1.8M | 944.0K | |
Total Stockholder Equity | 22.0M | (559K) | 29.7M | 16.4M | 3.4M | 3.8M | |
Retained Earnings | (53.8M) | (87.7M) | (93.8M) | (108.7M) | (121.7M) | (115.6M) | |
Common Stock Shares Outstanding | 72.1M | 82.0M | 120.0M | 123.7M | 124.2M | 130.5M | |
Total Liab | 11.9M | 22.4M | 5.3M | 1.8M | 3.2M | 2.5M | |
Common Stock | 72.6M | 83.2M | 118.0M | 118.1M | 118.2M | 124.1M | |
Total Assets | 33.9M | 21.9M | 35.0M | 18.1M | 6.7M | 7.2M | |
Net Debt | (18.4M) | (15.0M) | (29.3M) | (10.3M) | (989K) | (1.0M) | |
Accounts Payable | 1.1M | 978K | 757K | 1.1M | 635K | 650.4K | |
Cash | 19.6M | 15.9M | 30.1M | 11.0M | 3.1M | 4.0M | |
Cash And Short Term Investments | 19.7M | 15.9M | 30.1M | 15.0M | 3.2M | 4.2M | |
Net Receivables | 654.2K | 289K | 89K | 282K | 166K | 127.4K | |
Liabilities And Stockholders Equity | 33.9M | 21.9M | 35.0M | 18.1M | 6.7M | 7.2M | |
Other Current Assets | 201.3K | 561K | 679K | 643K | 619K | 650.0K | |
Total Current Assets | 20.8M | 17.0M | 31.3M | 16.2M | 4.2M | 4.5M | |
Other Stockholder Equity | 3.3M | 4.3M | 5.9M | 7.3M | 7.3M | 6.9M | |
Property Plant And Equipment Net | 6.7M | 4.7M | 3.7M | 1.9M | 2.4M | 2.7M | |
Non Current Assets Total | 13.1M | 4.8M | 3.7M | 1.9M | 2.5M | 3.2M | |
Property Plant Equipment | 6.5M | 4.7M | 3.6M | 1.9M | 2.2M | 2.6M | |
Short Term Investments | 90.9K | 561K | 679K | 4.0M | 20K | 19K | |
Net Tangible Assets | 835.0K | 15.5M | (624K) | 29.6M | 34.1M | 35.8M |
Pair Trading with Willow Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Willow Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Willow Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Willow Stock
0.84 | CMC | Cielo Waste Solutions Earnings Call This Week | PairCorr |
Moving against Willow Stock
The ability to find closely correlated positions to Willow Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Willow Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Willow Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Willow Biosciences to buy it.
The correlation of Willow Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Willow Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Willow Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Willow Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Willow Stock
Balance Sheet is a snapshot of the financial position of Willow Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Willow Biosciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Willow Biosciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Willow currently owns. An asset can also be divided into two categories, current and non-current.